628 related articles for article (PubMed ID: 17875480)
41. Significance of protein elicitor isolated from Tuber melanosporum on the production of ganoderic acid and Ganoderma polysaccharides during the fermentation of Ganoderma lucidum.
Zhu LW; Tang YJ
Bioprocess Biosyst Eng; 2010 Oct; 33(8):999-1005. PubMed ID: 20369259
[TBL] [Abstract][Full Text] [Related]
42. Lanostane-type triterpenoids from the mycelial mat of Ganoderma lucidum and their hepatoprotective activities.
Zhang X; Gao X; Long G; Yang Y; Chen G; Hou G; Huo X; Jia J; Wang A; Hu G
Phytochemistry; 2022 Jun; 198():113131. PubMed ID: 35248578
[TBL] [Abstract][Full Text] [Related]
43. [Study on variation of main ingredients from spores and fruiting bodies of Ganoderma lucidum].
Li JJ; Hu XQ; Zhang XF; Liu JJ; Cao LS
Zhongguo Zhong Yao Za Zhi; 2014 Nov; 39(21):4246-51. PubMed ID: 25775802
[TBL] [Abstract][Full Text] [Related]
44. Ganoderma lucidum spore extract inhibits endothelial and breast cancer cells in vitro.
Lu QY; Sartippour MR; Brooks MN; Zhang Q; Hardy M; Go VL; Li FP; Heber D
Oncol Rep; 2004 Sep; 12(3):659-62. PubMed ID: 15289852
[TBL] [Abstract][Full Text] [Related]
45. Submerged cultivation of medicinal mushrooms for production of valuable bioactive metabolites.
Zhong JJ; Tang YJ
Adv Biochem Eng Biotechnol; 2004; 87():25-59. PubMed ID: 15217103
[TBL] [Abstract][Full Text] [Related]
46. Triterpenes and Soluble Polysaccharide Changes in Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), During Fruiting Growth.
Zhou S; Tang Q; Tang C; Liu Y; Ma F; Zhang X; Zhang JS
Int J Med Mushrooms; 2018; 20(9):859-871. PubMed ID: 30317980
[TBL] [Abstract][Full Text] [Related]
47. Production of biomass and polysaccharides of Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (W.Curt. :Fr.) P. Karst. (higher Basidiomycetes), by submerged cultivation.
Habijanic J; Berovic M; Boh B; Wraber B; Petravic-Tominac V
Int J Med Mushrooms; 2013; 15(1):81-90. PubMed ID: 23510287
[TBL] [Abstract][Full Text] [Related]
48. Use of
González A; Atienza V; Montoro A; Soriano JM
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32325828
[TBL] [Abstract][Full Text] [Related]
49. Submerged fermentation production and characterization of intracellular triterpenoids from Ganoderma lucidum using HPLC-ESI-MS.
Cui ML; Yang HY; He GQ
J Zhejiang Univ Sci B; 2015 Dec; 16(12):998-1010. PubMed ID: 26642183
[TBL] [Abstract][Full Text] [Related]
50. Conditions Affecting Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Basidiome Quality, Morphogenesis, and Biodegradation of Wood By-products in Argentina.
Kuhar F; Postemsky PD; Bianchinotti MV
Int J Med Mushrooms; 2018; 20(5):495-506. PubMed ID: 29953364
[TBL] [Abstract][Full Text] [Related]
51. Anti-inflammatory triterpenoids from mysterious mushroom Ganoderma lucidum and their potential possibility in modern medicine.
Patocka J
Acta Medica (Hradec Kralove); 1999; 42(4):123-5. PubMed ID: 10812678
[TBL] [Abstract][Full Text] [Related]
52. Anticomplement activity of terpenoids from the spores of Ganoderma lucidum.
Min BS; Gao JJ; Hattori M; Lee HK; Kim YH
Planta Med; 2001 Dec; 67(9):811-4. PubMed ID: 11745016
[TBL] [Abstract][Full Text] [Related]
53. Improvement of ganoderic acid and Ganoderma polysaccharide biosynthesis by Ganoderma lucidum fermentation under the inducement of Cu2+.
Tang YJ; Zhu LW
Biotechnol Prog; 2010; 26(2):417-23. PubMed ID: 19953599
[TBL] [Abstract][Full Text] [Related]
54. Effect of heat stress on production and in-vitro antioxidant activity of polysaccharides in Ganoderma lucidum.
Tan X; Sun J; Xu Z; Li H; Hu J; Ning H; Qin Z; Pei H; Sun T; Zhang X
Bioprocess Biosyst Eng; 2018 Jan; 41(1):135-141. PubMed ID: 29018957
[TBL] [Abstract][Full Text] [Related]
55. Ganoderma lucidum: Multifaceted mechanisms to combat diabetes through polysaccharides and triterpenoids: A comprehensive review.
Ahmad MF; Ahmad FA; Hasan N; Alsayegh AA; Hakami O; Bantun F; Tasneem S; Alamier WM; Babalghith AO; Aldairi AF; Kambal N; Elbendary EY
Int J Biol Macromol; 2024 May; 268(Pt 1):131644. PubMed ID: 38642691
[TBL] [Abstract][Full Text] [Related]
56. [Isolation, purification and structural characterization of active polysaccharides from the mycelium of Ganoderma lucidum].
Zhao C; He Y
Zhong Yao Cai; 2002 Apr; 25(4):252-4. PubMed ID: 12583175
[TBL] [Abstract][Full Text] [Related]
57. Ganoderma lucidum: A rational pharmacological approach to surmount cancer.
Ahmad MF
J Ethnopharmacol; 2020 Oct; 260():113047. PubMed ID: 32504783
[TBL] [Abstract][Full Text] [Related]
58. [Effect of light quality on growth and polysaccharides content of Ganoderma lucidum].
Hao J; Chen X; Lan J
Zhongguo Zhong Yao Za Zhi; 2010 Sep; 35(17):2242-5. PubMed ID: 21137329
[TBL] [Abstract][Full Text] [Related]
59. Biotechnological production and application of ganoderic acids.
Xu JW; Zhao W; Zhong JJ
Appl Microbiol Biotechnol; 2010 Jun; 87(2):457-66. PubMed ID: 20437236
[TBL] [Abstract][Full Text] [Related]
60. Anti-diabetic effects of Ganoderma lucidum.
Ma HT; Hsieh JF; Chen ST
Phytochemistry; 2015 Jun; 114():109-13. PubMed ID: 25790910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
